Open-label, non-randomized, prospective, single center, observational, translational study
The aim of this trial is to study immunosuppression biomarkers in patients hospitalized in intensive care unit in comparison to non-septic patients. Prevalence of immunosuppression acquired in intensive care unit will be studied and patients most likely to develop nosocomial infection will be early identified
Study Type
OBSERVATIONAL
Enrollment
44
CHU de Rennes
Rennes, France
Detection of immunosuppression biomarkers in septic and non-septic patients hospitalized in intensive care unit
Time frame: Day 14
Association of immunosuppression biomarkers with occurrence of events reflecting a clinical immunosuppression
Study of CMV reactivation and nosocomial infections
Time frame: Day 14
Association of immunosuppression biomarkers with patients demographic data
Record of patient age and gender
Time frame: Day 14
Association of immunosuppression biomarkers with patients clinical data
Record of severity score, duration of hospitalization, duration of mechanical ventilation, morbidity
Time frame: Day 14
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.